These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31398086)

  • 21. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
    De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
    Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus and adeno-associated virus vectors.
    Lai CM; Lai YK; Rakoczy PE
    DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic Concepts in Viral Vector-Mediated Gene Therapy.
    Benskey MJ; Sandoval IM; Miller K; Sellnow RL; Gezer A; Kuhn NC; Vashon R; Manfredsson FP
    Methods Mol Biol; 2019; 1937():3-26. PubMed ID: 30706387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adeno-associated virus and lentivirus pseudotypes for lung-directed gene therapy.
    Wilson JM
    Proc Am Thorac Soc; 2004; 1(4):309-14. PubMed ID: 16113451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The status of gene vectors for the treatment of diabetes.
    Zaia JA
    Cell Biochem Biophys; 2007; 48(2-3):183-90. PubMed ID: 17709888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors.
    Srivastava A
    J Cell Biochem Suppl; 2002; 38():39-45. PubMed ID: 12046848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the Relationship of Viral Particles and Extracellular Vesicles: Implications for Viral Vector Technology.
    Metzner C; Zaruba M
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vectors for gene therapy of cardiovascular disease.
    Dedieu JF; Mahfoudi A; Le Roux A; Branellec D
    Curr Cardiol Rep; 2000 Jan; 2(1):39-47. PubMed ID: 10980871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.
    Vandendriessche T; Thorrez L; Acosta-Sanchez A; Petrus I; Wang L; Ma L; DE Waele L; Iwasaki Y; Gillijns V; Wilson JM; Collen D; Chuah MK
    J Thromb Haemost; 2007 Jan; 5(1):16-24. PubMed ID: 17002653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adeno-associated virus (AAV) vectors in cancer gene therapy.
    Santiago-Ortiz JL; Schaffer DV
    J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.
    Kasala D; Yoon AR; Hong J; Kim SW; Yun CO
    Nanomedicine (Lond); 2016 Jul; 11(13):1689-713. PubMed ID: 27348247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response following intraocular delivery of recombinant viral vectors.
    Bennett J
    Gene Ther; 2003 Jun; 10(11):977-82. PubMed ID: 12756418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging adenoviral vectors for stable correction of genetic disorders.
    Jager L; Ehrhardt A
    Curr Gene Ther; 2007 Aug; 7(4):272-83. PubMed ID: 17969560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart.
    Merentie M; Lottonen-Raikaslehto L; Parviainen V; Huusko J; Pikkarainen S; Mendel M; Laham-Karam N; Kärjä V; Rissanen R; Hedman M; Ylä-Herttuala S
    Gene Ther; 2016 Mar; 23(3):296-305. PubMed ID: 26704723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral vector-mediated gene therapy for opioid use disorders.
    Wang T; Zhu X; Yi H; Gu J; Liu S; Izenwasser S; Lemmon VP; Roy S; Hao S
    Exp Neurol; 2021 Jul; 341():113710. PubMed ID: 33781732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Delivery of Adeno-Associated Viral Vectors in Mice and Dogs.
    Wasala LP; Hakim CH; Yue Y; Yang NN; Duan D
    Methods Mol Biol; 2019; 1937():281-294. PubMed ID: 30706404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector.
    Ikeda Y; Sun Z; Ru X; Vandenberghe LH; Humphreys BD
    J Am Soc Nephrol; 2018 Sep; 29(9):2287-2297. PubMed ID: 29976586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.